PTGIR and pulmonary arterial hypertension: The prostacyclin analogs, such as iloprost and selexipag, are used to treat pulmonary arterial hypertension due to their vasodilatory and anti-platelet effects through activation of the prostacyclin receptor (Sitbon et al., 2015; Mandras et al., 2021).